• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Oxolanes Oxolanes
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Oxolanes

Professional Introduction to (3R,5S)-5-(Hydroxymethyl)tetrahydrofuran-3-ol (CAS No. 259539-06-5)

(3R,5S)-5-(Hydroxymethyl)tetrahydrofuran-3-ol (CAS No. 259539-06-5) is a significant compound in the field of chemical and pharmaceutical research, characterized by its unique stereochemical configuration and functional properties. This compound has garnered considerable attention due to its potential applications in drug development and synthetic chemistry. The precise stereochemistry of this molecule, denoted by the (3R,5S) configuration, plays a crucial role in determining its biological activity and interaction with biological targets.

The structural motif of tetrahydrofuran-3-ol provides a versatile scaffold for the design of bioactive molecules. The presence of a hydroxymethyl group at the 5-position enhances the compound's reactivity and allows for further functionalization, making it a valuable intermediate in synthetic pathways. Recent advancements in medicinal chemistry have highlighted the importance of such chiral compounds in developing enantiomerically pure drugs, which often exhibit improved pharmacological profiles compared to their racemic counterparts.

In recent years, research has demonstrated the utility of (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol as a key intermediate in the synthesis of various pharmacologically relevant compounds. For instance, studies have explored its role in the development of novel antiviral agents, where its structural features contribute to enhanced binding affinity and selectivity towards viral proteases. The stereochemical purity of this compound is particularly critical in such applications, as even minor deviations from the desired configuration can significantly impact the efficacy and safety of the final therapeutic agent.

Furthermore, the compound's ability to undergo selective modifications at the hydroxymethyl group has opened up new avenues for drug design. Researchers have leveraged this reactivity to introduce diverse functional groups, leading to the synthesis of analogues with tailored biological activities. For example, derivatives of (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol have been investigated for their potential as kinase inhibitors, showcasing the compound's versatility as a building block in medicinal chemistry.

The synthesis of (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol itself presents an intriguing challenge due to its complex stereochemistry. Advanced synthetic methodologies, including asymmetric hydrogenation and enzymatic resolution techniques, have been employed to achieve high enantiomeric purity. These methods not only highlight the synthetic prowess required to produce such compounds but also underscore their importance in modern drug discovery efforts.

In addition to its pharmaceutical applications, (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol has found utility in materials science and catalysis. Its unique structural features make it a promising candidate for designing novel catalysts and ligands that can enhance reaction efficiencies in various chemical transformations. The compound's ability to act as a chiral auxiliary has been particularly valuable in asymmetric synthesis, where it aids in achieving high enantiomeric excesses in product formation.

Recent studies have also explored the potential of (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol in green chemistry initiatives. Its biodegradability and low toxicity profile make it an attractive alternative to traditional synthetic intermediates that may pose environmental concerns. By incorporating this compound into sustainable synthetic routes, researchers aim to minimize waste generation and reduce the overall environmental footprint of drug production processes.

Looking ahead, the future prospects for (3R,5S)-5-(hydroxymethyl)tetrahydrofuran-3-ol appear promising as new research continues to uncover its diverse applications. Ongoing investigations are focused on expanding its utility in drug discovery, materials science, and catalysis while adhering to principles of sustainability and efficiency. As our understanding of this compound grows, so too will its significance in advancing scientific and technological innovation.

• 97-99-4(Tetrahydrofurfuryl alcohol)
• 41107-82-8(2,5-Anhydro-D-mannitol)
• 86087-23-2((S)-Tetrahydrofuran-3-ol)
• 5306-85-4(Isosorbide dimethyl ether)
• 62435-71-6(Ethyl tetrahydrofurfuryl ether)
• 31692-85-0(GLYCOFUROL)
• 652-67-5(Isosorbide)
• 86087-24-3((3R)-oxolan-3-ol)
• 27826-73-9(2,5-Anhydro-D-glucitol)
• 453-20-3(oxolan-3-ol)